Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fabrizio Cantini and Laura Niccoli.
Fabrizio Cantini
Connection Strength
0.728
Laura Niccoli
  1. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review. Drugs. 2020 Dec; 80(18):1929-1946.
    View in: PubMed
    Score: 0.229
  2. Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study. J Infect. 2020 10; 81(4):647-679.
    View in: PubMed
    Score: 0.222
  3. Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact. J Infect. 2020 08; 81(2):318-356.
    View in: PubMed
    Score: 0.220
  4. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv. 2021 01; 7(1).
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.